The FDA announced that it has temporarily postponed all domestic routine surveillance facility inspections. These are facility inspections the FDA traditionally conducts every few years based on a risk analysis. Importantly, all domestic for-cause inspection assignments will be evaluated and will proceed on a case-by-case basis if deemed mission-critical. For example, food facilities experiencing a Class I recall may still reasonably expect an inspection. During this interim period, the FDA is evaluating additional ways to conduct for-cause inspections including, among other things, evaluating records in lieu of conducting an onsite inspection. Earlier in the month, the FDA postponed most foreign inspections through April 2020.
Alerts
FDA Scales Back Domestic Inspections Amid COVID-19 Pandemic.
Media Contacts
- Jacob Bourne
- Director of Media Relations
Related People
